Resverlogix starts enrolment and dosing in Phase IIb Covid-19 therapy trial
Resverlogix has initiated enrolment and dosing in a Phase IIb trial of apabetalone (RVX-208) as a possible oral therapy to treat Covid-19.
Source: clinicaltrialsarena.com
Biomedical Panel News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Biomedical Panel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Biomedical Panel Today - Breaking & Trending Today
Resverlogix holds discussions with Morocco to start Covid-19 drug trial
Resverlogix is holding talks with the Ministry of Health of the Kingdom of Morocco to conduct Phase II trials of apabetalone for Covid-19.
Source: pharmaceutical-technology.com
Resverlogix Receives Ethics Approval for Canadian Sites in
Study Approval Paves the Way for Trial Participants to Begin Taking Apabetalone...
Source: globenewswire.com
Resverlogix Receives Ethics Approval for Canadian Sites in Apabetalone COVID-19 Clinical Trial
Study Approval Paves the Way for Trial Participants to Begin Taking Apabetalone
Source: leaderpost.com